These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 15382196)

  • 1. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: a 10-year experience.
    Choi EK; Hong CH; Kim MJ; Im YJ; Jung HJ; Han SW
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):798-803. PubMed ID: 23177928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida.
    Xiao CG; Du MX; Li B; Liu Z; Chen M; Chen ZH; Cheng P; Xue XN; Shapiro E; Lepor H
    J Urol; 2005 Jun; 173(6):2112-6. PubMed ID: 15879861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
    Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
    BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.
    Wang QW; Song DK; Zhang XP; Wu YD; Zhang RL; Wei JX; Wen JG
    Urol Int; 2011; 86(4):461-5. PubMed ID: 21555862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oxybutynin on structural changes of the obstructed guinea pig bladder.
    Scheepe JR; de Jong BW; Wolffenbuttel KP; Arentshorst ME; Lodder P; Kok DJ
    J Urol; 2007 Oct; 178(4 Pt 2):1807-12. PubMed ID: 17707007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
    Buyse G; Verpoorten C; Vereecken R; Casaer P
    Eur J Pediatr Surg; 1995 Dec; 5 Suppl 1():31-4. PubMed ID: 8770576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the absence of anal reflexes guarantee a "safe bladder" in children with spina bifida?
    Marshall DF; Boston VE
    Eur J Pediatr Surg; 2001 Dec; 11 Suppl 1():S21-3. PubMed ID: 11813129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.
    Kajbafzadeh AM; Sharifi-Rad L; Baradaran N; Nejat F
    Urology; 2009 Aug; 74(2):324-9. PubMed ID: 19476983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity.
    Cartwright PC; Coplen DE; Kogan BA; Volinn W; Finan E; Hoel G
    J Urol; 2009 Oct; 182(4):1548-54. PubMed ID: 19683731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
    Grigoleit U; Mürtz G; Laschke S; Schuldt M; Goepel M; Kramer G; Stöhrer M
    Eur Urol; 2006 Jun; 49(6):1114-20; discussion 1120-1. PubMed ID: 16542772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of bowel management on urodynamic findings in spina bifida children with detrusor overactivity and detrusor sphincter dyssynergia.
    Milivojevic S; Milic N; Lazovic JM; Radojicic Z
    J Pediatr Urol; 2020 Oct; 16(5):556.e1-556.e7. PubMed ID: 32376289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting renal scar development in children with spina bifida.
    Ozel SK; Dokumcu Z; Akyildiz C; Avanoglu A; Ulman I
    Urol Int; 2007; 79(2):133-6. PubMed ID: 17851282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiology and evaluation of overactive bladder].
    Amarenco G; Leroi AM
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):358-66. PubMed ID: 12746711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.